首页 › 基金 › MPM BioImpact LLC › ZURA
MPM BioImpact LLC 对 ZURA 的持仓历史
ZURA BIO LTD · 医疗保健
MPM BioImpact LLC 在 Q3 2026 的 13F 申报中披露持有 ZURA(ZURA BIO LTD)4,449,671 股,市值约 US$18.5M,约占其申报组合的 1.42%,在其申报持仓中市值排名第 30 位。 MPM BioImpact LLC 最近 2 个申报季度中有 2 个季度披露了 ZURA 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
MPM BioImpact LLC 对 ZURA 的持仓演变
MPM BioImpact LLC 于 Q2 2026 首次披露 ZURA 持仓:4,472,843 股(约 US$26.4M)。 在 2 次申报中,MPM BioImpact LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 4,449,671 股、市值约 US$18.5M,环比减持 -23,172 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 4.47M | $26.39M | 新进 |
| Q3 2026 | 4.45M | $18.51M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ZURA 与 13F 数据
ZURA(ZURA BIO LTD)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 ZURA,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$39.3M), Venrock Adviser, LLC (US$26.8M), GREAT POINT PARTNERS LLC (US$17.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ZURA 的基金
- MONTANOVA CAPITAL, LLC 9.44M 股 · $39.28M · Q3 2026
- Venrock Adviser, LLC 6.43M 股 · $26.77M · Q3 2026
- GREAT POINT PARTNERS LLC 4.08M 股 · $16.96M · Q3 2026
- Commodore Capital LP 3.25M 股 · $13.52M · Q3 2026
- Saturn V Capital Management LP 2.03M 股 · $8.46M · Q3 2026
- Vestal Point Capital, LP 1.86M 股 · $7.74M · Q3 2026
- Foresite Capital Management VI LLC 1.76M 股 · $7.31M · Q3 2026
- QVT Financial LP 1.67M 股 · $6.94M · Q3 2026
- Squadron Capital Management LLC 1.20M 股 · $4.99M · Q3 2026
- Ikarian Capital, LLC 1.02M 股 · $4.24M · Q3 2026
- Blue Owl Capital Holdings LP 735.00K 股 · $3.06M · Q3 2026
- EcoR1 Capital, LLC 679.72K 股 · $2.83M · Q3 2026
更多关于 MPM BioImpact LLC
常见问题
How long has MPM BioImpact LLC held ZURA?
MPM BioImpact LLC has disclosed ZURA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is MPM BioImpact LLC's current position in ZURA?
As of Q3 2026, MPM BioImpact LLC holds 4.45M shares of ZURA (ZURA BIO LTD), valued at $18.51M, representing 1.42% of its reported portfolio and ranking #30.
Has MPM BioImpact LLC been buying or selling ZURA?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC reduced its position in ZURA.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, GREAT POINT PARTNERS LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.